Cited by 195Alzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Epidermal growth factor receptor is a preferred target for treating Amyloid-β–induced memory loss

Open access

Wang, Lei, Chiang, Hsueh-Cheng, Wu, Wenjuan, Liang, Bin, Xie, Zuolei, Yao, Xinsheng, Ma, Weiwei, Du, Shuwen, Zhong, Yi·2012·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1208011109PMC PMC3478595

Open this paper in CoChat — free account

Abstract

Current understanding of amyloid-β (Aβ) metabolism and toxicity provides an extensive list of potential targets for developing drugs for treating Alzheimer’s disease. We took two independent approaches, including synaptic-plasticity–based analysis and behavioral screening of synthetic compounds, for identifying single compounds that are capable of rescuing the Aβ-induced memory loss in both transgenic fruit fly and transgenic mouse models. Two clinically available drugs and three synthetic compounds not only showed positive effects in behavioral tests but also antagonized the Aβ oligomers-induced activation of the epidermal growth factor receptor (EGFR). Such surprising converging outcomes from two parallel approaches lead us to conclude that EGFR is a preferred target for treating Aβ-induced memory loss.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.1208011109

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
Retracted
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
The discovery of receptor tyrosine kinases: targets for cancer therapy
Gschwind, A., Fischer, O. M., & Ullrich, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1360 · Cited by 1,227
Alzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217
Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207

Show all 45 references

Sorted by citations

Items 101–195 of 195

Co-Expression Analysis of microRNAs and Proteins in Brain of Alzheimer’s Disease Patients
Watson, C. N., Begum, G., Ashman, E., Thorn, D., Yakoub, K. M., Hariri, M. A., Nehme, A., Mondello, S., Kobeissy, F. H., Belli, A., et al. (2022) · Cells · doi:10.3390/cells11010163 · Cited by 12
Drosophila as a Model System for the Identification of Pharmacological Therapies in Neurodegenerative Diseases
Solana‐Manrique, C., Moltó, M. D., Calap-Quintana, P., Sanz, F., Llorens, J. V., & Paricio, N. (2019) · Springer eBooks · doi:10.1007/978-981-13-2218-1_15 · Cited by 12
ER-organelle contacts: A signaling hub for neurological diseases
Wang, Y., & Yang, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107149 · Cited by 15
Unraveling the transcriptomic landscape of brain vascular cells in dementia: A systematic review
Sewell, M. D. E., Fialova, N., & Montagne, A. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14512 · Cited by 13
Validating a Genomic Convergence and Network Analysis Approach Using Association Analysis of Identified Candidate Genes in Alzheimer’s Disease
Talwar, P., Kushwaha, S. S., Rawat, C., Kaur, H., Srivastava, A., Agarwal, R., Chandna, P., Tucci, P., Saso, L., & Kukreti, R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.722221 · Cited by 11
PathFinder: a novel graph transformer model to infer multi-cell intra- and inter-cellular signaling pathways and communications
Feng, J., Song, H., Province, M. A., Li, G., Payne, P., Chen, Y., & Li, F. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1369242 · Cited by 13
Dammarane-type saponins from Gynostemma pentaphyllum and their potential anti-AD activity
Wang, J., Li, C., Farimani, M. M., & Yang, J. (2019) · Phytochemistry Letters · doi:10.1016/j.phytol.2019.03.022 · Cited by 11
Erlotinib regulates short-term memory, tau/Aβ pathology, and astrogliosis in mouse models of AD
Lee, H., Hwang, J.-W., Kim, J., Jo, A.-R., Park, J.-H., Jeong, Y. J., Jang, J.-Y., Kim, S., Song, J.-H., & Hoe, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1421455 · Cited by 10
Novel Drosophila model for parkinsonism by targeting phosphoglycerate kinase
Shimizu, J., Kasai, T., Yoshida, H., Huynh, M. A., Nakao-Azuma, Y., Shinomoto, M., Tokuda, T., Mizuno, T., & Yamaguchi, M. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104816 · Cited by 9
Biomarker Genes Discovery of Alzheimer’s Disease by Multi-Omics-Based Gene Regulatory Network Construction of Microglia
Gao, W., Kong, W., Wang, S., Wen, G., & Yu, Y. (2022) · Brain Sciences · doi:10.3390/brainsci12091196 · Cited by 9
Receptor tyrosine kinases
Pulivarthi, C. B., Choubey, S. S., Pandey, S. K., Gautam, A. S., & Singh, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00011-7 · Cited by 9
Repositioning of receptor tyrosine kinase inhibitors
Mansour, H. M., & El-Khatib, A. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00010-5 · Cited by 9
Reduced Smoothened level rescues Aβ-induced memory deficits and neuronal inflammation in animal models of Alzheimer's disease
Ma, W., Wu, M., Zhou, S., Tao, Y., Xie, Z., & Zhong, Y. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2018.05.001 · Cited by 9
Self-citation
In Silico Prediction of Quercetin Analogs for Targeting Death-Associated Protein Kinase 1 (DAPK1) Against Alzheimer’s Disease
Sun, Y., Zhao, J. W., Lu, Y., Ngo, F. Y., Shuai, B., Zhang, Z., Feng, Y., & Rong, J. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240515090434 · Cited by 8
Neuronal fatty acid-binding protein enhances autophagy and suppresses amyloid-β pathology in a Drosophila model of Alzheimer’s disease
Jang, S., Choi, B., Lim, C., Kim, M., Lee, J., Lee, H., Baek, E., & Cho, K. S. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011475 · Cited by 8
VariFunNet, an integrated multiscale modeling framework to study the effects of rare non-coding variants in genome-wide association studies: Applied to Alzheimer's disease
Liu, Q., Chen, C., Gao, A., Tong, H., & Xie, L. (2017) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2017.8217995 · Cited by 8
Cloning and characterisation of NMDA receptors in the Pacific oyster, Crassostrea gigas (Thunberg, 1793) in relation to metamorphosis and catecholamine synthesis
Vogeler, S., Carboni, S., Li, X., Ireland, J. H., Miller-Ezzy, P., & Joyce, A. (2020) · Developmental Biology · doi:10.1016/j.ydbio.2020.10.008 · Cited by 8
Integrative Computational Network Analysis Reveals Site-Specific Mediators of Inflammation in Alzheimer's Disease
Ravichandran, S., Michelucci, A., & del Sol, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00154 · Cited by 8
Housefly ( Musca domestica ) larvae powder, preventing oxidative stress injury via regulation of UCP4 and CyclinD1 and modulation of JNK and P38 signaling in APP/PS1 mice
He, Y., Yang, X., Jiao, M., Anoopkumar‐Dukie, S., Zeng, Y., & Mei, H. (2018) · Food & Function · doi:10.1039/c8fo02052c · Cited by 7
Rac1 and Akt Exhibit Distinct Roles in Mediating Aβ-Induced Memory Damage and Learning Impairment
Cheng, K., Chen, Y., Wu, C., Lee, W.-P., Cheung, C. H. A., & Chiang, H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02471-1 · Cited by 7
Self-citation
Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer’s Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling
Yuen, S. C., Lee, S. M., & Leung, S.-W. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215349 · Cited by 7
Combined Metabolic Activators Improves Cognitive Functions in Alzheimer's DiseasePreprint
Yuluğ, B., Altay, Ö., Li, X., Hanoğlu, L., Çankaya, Ş., Lam, S. C. C., Yang, H., Coşkun, E., İdil, E., Nogaylar, R., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3924201 · Cited by 7
Differential gene expression analysis based on linear mixed model corrects false positive inflation for studying quantitative traits
Tang, S., Buchman, A. S., Wang, Y., Avey, D. R., Xu, J., Tasaki, S., Bennett, D. A. A., Zheng, Q., & Yang, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-43686-7 · Cited by 7
Neuroprotective effect of chrysophanol in Alzheimer disease via modulating the Ca2+/EGFR-PLCγ pathway
Huang, W. G., Chen, Q., Zhou, P., Ye, S., & Fang, Z. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137684 · Cited by 6
Developing theragnostics for Alzheimer's disease: Insights from cancer treatment
Lee, H., Choi, H.-J., Jeong, Y. J., Na, Y., Hong, J. T., Han, J. M., Hoe, H., & Lim, K. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131925 · Cited by 6
The active components of Erzhi wan and their anti-Alzheimer's disease mechanisms determined by an integrative approach of network pharmacology, bioinformatics, molecular docking, and molecular dynamics simulation
Yu, M., Shen, Z., Zhang, S., Zhang, Y., Zhao, H., & Zhang, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33761 · Cited by 6
The molecular genetic landscape of human brain size variation
Seidlitz, J., Mallard, T. T., Vogel, J. W., Lee, Y. A., Warrier, V., Ball, G., Hansson, O., Hernandez, L. M., Mandal, A. S., Wagstyl, K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113439 · Cited by 6
Preference matrix guided sparse canonical correlation analysis for mining brain imaging genetic associations in Alzheimer's disease
Sha, J., Bao, J., Liu, K., Yang, S., Wen, Z., Wen, J., Cui, Y., Tong, B., Moore, J. H., Saykin, A. J., et al. (2023) · Methods · doi:10.1016/j.ymeth.2023.07.007 · Cited by 6
Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)
Aliashrafzadeh, H., Liu, D., Alba, S. D., Akbar, I., Lui, A., Vanleuven, J., Martin, R. M., Wang, Z., & Liu, D. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.1008116 · Cited by 5
Systematic analysis of the potential off-target activities of osimertinib by computational target fishing
Chen, S.-J., Bi, Y.-H., & Zhang, L.-H. (2021) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001229 · Cited by 5
Microarray meta-analysis reveals comprehensive effects of 3,4,5-tricaffeolyquinic acid in cell differentiation and signaling
Chen, A., Ferdousi, F., Bejaoui, M., Sasaki, K., & Isoda, H. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176143 · Cited by 5
Multi-Omics Integration Analysis Pinpoint Proteins Influencing Brain Structure and Function: Toward Drug Targets and Neuroimaging Biomarkers for Neuropsychiatric Disorders
Wang, Y., Zhang, S., Gong, W., Liu, X., Mo, Q., Shen, L., Zhao, Y., Wang, S., & Yuan, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179223 · Cited by 5
Phosphokinase Antibody Arrays on Dendron-Coated Surface
Kwak, J., Jeong, H., Han, S.-H., Kim, Y., Son, S. M., Mook‐Jung, I., Hwang, D., & Park, J. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096456 · Cited by 5
Development of Plasma Protein Classification Models for Alzheimer’s Disease Using Multiple Machine Learning Approaches
Tsurumi, A., Cahill, C. M., Liu, A., Chatterjee, P., Das, S., & Kobayashi, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311673 · Cited by 5
EGFR–Annexin A2 signaling–mediated tauopathy in amyloid-β and aluminum chloride–induced Alzheimer’s disease and its modulation by the HDAC inhibitor butyrate
Jayaswamy, P. K., Ambrish, T., Sangamesh, V. C., Kabekkodu, S. P., Kellarai, A., Shetty, J., & Shetty, P. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.119775 · Cited by 4
The β-alanyl-monoamine synthase ebony is regulated by schizophrenia susceptibility gene dysbindin in Drosophila
Lu, B., Shao, L., Feng, S., Wang, T., & Zhong, Y. (2014) · Science China Life Sciences · doi:10.1007/s11427-013-4595-9 · Cited by 4
Self-citation
Differential hippocampal protein expression between normal mice and mice with the perioperative neurocognitive disorder: a proteomic analysis
Li, C., Li, J., He, T., Shan, J., Liu, F., Deng, X., Lin, Y., Xu, L., Fu, L., Wang, B., et al. (2021) · European journal of medical research · doi:10.1186/s40001-021-00599-3 · Cited by 4
Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease
Lee, H., & Hoe, H. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369108 · Cited by 4
Arbutin in Alzheimer’s disease: A network-based approach to uncover drug targets through molecular mapping
Uvarajan, D., Ravikumar, M., & Durairaj, B. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100295 · Cited by 4
The interference between SARS-COV-2 and Alzheimer’s disease: Potential immunological and neurobiological crosstalk from a kinase perspective reveals a delayed pandemic
Mansour, H. M. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102195 · Cited by 3
Exploring the causal relationship and molecular mechanisms between Methyl-4-hydroxybenzoic acid (MEP) and Alzheimer’s disease: a mendelian randomization, multi-omics, and network toxicology approach
Gong, H., Li, J., Pu, R., & Huang, J. (2025) · Toxicology Research · doi:10.1093/toxres/tfaf113 · Cited by 3
Insights into receptor tyrosine kinases signaling in neurodegenerative disorders
Randhawa, P. K., Jaggi, A. S., & Bali, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00001-4 · Cited by 3
Exploring Acori Tatarinowii Rhizoma and Polygalae Radix in Alzheimer’s: Network pharmacology and molecular docking analysis
Tong, T., Cheng, B., Tie, S., Ouyang, D., & Cao, J. (2024) · Medicine · doi:10.1097/md.0000000000037740 · Cited by 3
The anti-inflammatory drug Montelukast ameliorates cognitive deficits by rescuing the inflammatory levels in young AD animal models
Wu, M., Chen, Y., Yao, W., Zhou, S., Xie, Z., Tao, Y., Zhong, Y., & Ma, W. (2025) · Scientific Reports · doi:10.1038/s41598-025-91785-4 · Cited by 3
Self-citation
Computational Fragment‐Based Design of Phytochemical Derivatives as EGFR Inhibitors
Bhat, G. S., & Mohammad, F. S. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202300681 · Cited by 3
Alternative Models in Drug Discovery and Development Part II: In Vivo Nonmammalian and Exploratory/Experimental Human Models
Romero, L. I., & Vela, J. M. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527679348.ch03 · Cited by 3
Distinct forms of amyloid-β moderate sleep duration through NAD + -linked redox metabolism in Alzheimer’s diseasePreprint
Yu, Y., Fedele, G., Celardo, I., Zhou, L., Tan, B. W. Z., Loh, S. H. Y., & Martins, L. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.26.640405 · Cited by 3
Epidermal growth factor receptor modulation for neural repair: Implications for neurodegenerative disease therapy
Amin, A., & Badenes, M. (2026) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2026.1891964 · Cited by 2
Simple In Vivo Models of Alzheimer’s Disease
Caito, S. W., & Newell-Caito, J. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802810-0.00011-8 · Cited by 2
Effect of the glycine-rich domain in GAREM2 on its unique subcellular localization upon EGF stimulation
Nishino, T., Oshika, T., Kyan, M., & Konishi, H. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00260-1 · Cited by 2
Targeting Aβ Receptors to Modify Alzheimer’s Disease Progression
Haas, L. T., & Strittmatter, S. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00008-3 · Cited by 2
Disrupted cellular calcium homeostasis is responsible for Aβ‐induced learning and memory damage and lifespan shortening in a model of Aβ transgenic fly
Cheng, K., Huang, C., Hsieh, T., & Chiang, H. (2022) · IUBMB Life · doi:10.1002/iub.2621 · Cited by 2
Self-citation
Lower Plasma Amyloid Beta - 42 Levels Associated With Worse Survival in Patients With Glioma
Seo, K., Hwang, K., Noh, M., Park, J. J., Ahn, K., Ji, S. Y., Han, J. H., & Kim, C. (2023) · In Vivo · doi:10.21873/invivo.13455 · Cited by 1
Network Pharmacology of miR-146a-5p as a Potential Anti-Inflammatory Agent in Preventing Alzheimer's Disease
Lee, S., Foo, J. B., Yong, Y. K., Looi, Q. D., & Ooi, Y. (2025) · Current Alzheimer Research · doi:10.2174/0115672050383519250825060815 · Cited by 1
Diacylglycerol kinases: Molecular mechanism of cellular and physiological functions
Kimura, T., & Epand, R. M. (2026) · Progress in Lipid Research · doi:10.1016/j.plipres.2025.101373 · Cited by 2
The molecular mechanisms of Abyssinone-I protect against Alzheimer’s disease: an in-silico study
Nguyen, H. D. (2024) · Discover Medicine · doi:10.1007/s44337-024-00009-7 · Cited by 1
Current Therapeutic Options and Repurposed Drugs for Neurodegeneration
Dhaneshwar, S. S., Bhat, M. A., Singh, A., & Roy, S. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815238754124010012 · Cited by 1
Evidence based computational drug repositioning candidate screening pipeline design: Case Study
Zhu, Q., Liu, H., Zhang, Y., & Wang, J. (2014) · IEEE International Conference on Systems Biology · doi:10.1109/isb.2014.6990757 · Cited by 1
Growth factors and their receptors
Lazaldin, M. A. M., Lambuk, L., Ahmad, S., & Mohamud, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18677-6.00005-1 · Cited by 1
Pathways to dementia: genetic predictors of cognitive and brain imaging endophenotypes in Alzheimer's disease
Ramanan, V. K. (2014) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1951
Drosophila model of cognitive disorders: Focus on memory abnormality
Shao, L., & Zhong, Y. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9780511920585.013
Self-citation
Interaction of Genetics, Amyloid-Beta and Inflammation as Mediators of Brain Structure Change in Cognitive DeclinePreprint
Jin, Y., Petros Drineas, B., Rochet, C., & Paschou, P. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4088781
Comparison of the urinary proteome in depressed patients before and after modified electroconvulsive therapyPreprint
Tang, S., Guo, T., Sha, S., Wei, J., Liu, Y., Yang, J., Wang, G., & Gao, Y. (2023) · medRxiv · doi:10.1101/2023.05.24.23290254
Dementia incidence varied by anticancer drugs and molecular targeted therapy in a population-based cohort study
Lee, E. H., Kang, D., Lee, J., Seo, S. W., Kim, C., & Cho, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-68199-9
Remembering punishment-related odors: Insights from the Drosophila brain and its inspiration
Li, Q., & Zhong, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15754-7.00052-3
Self-citation
Urinary proteome comparison in modified electroconvulsive therapy in depression disorder：new approach in the therapeutic mechanismPreprint
Gao, Y., Tang, S., Guo, T., & Sha, S. (2024) · doi:10.22541/au.173082616.65573881/v1
PRÓPOLIS MARROM BRASILEIRA CONTRA DOENÇA DE ALZHEIMER EM MODELO IN SILICO
Callafatti, L. B., Tavares, M. S., dos Santos, J. F., Furtado, R. A., & de Almeida, S. (2024) · Congresso Internacional Multidisciplinar (CIM) · doi:10.56238/i-cim-059
PRÓPOLIS MARROM BRASILEIRA CONTRA DOENÇA DE ALZHEIMER EM MODELO IN SILICO
Callafatti, L. B., Tavares, M. S., Santos, J. F. D., Furtado, R. A., & de Almeida, S. (2024) · Aracê. · doi:10.56238/arev6n4-148
Old Drugs: Confronting Recent Advancements and Challenges
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6198-0
Urinary proteome comparison in modified electroconvulsive therapy in depression disorder：new approach in the therapeutic mechanismPreprint
Tang, S., Guo, T., Sha, S., Wei, J., Liu, Y., Yang, J., Wang, G., & Gao, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-6664029/v1
Chronic oral administration of ibrutinib prevents long-term memory deficits and reduces AD pathology and neuroinflammatory responses in a mouse model of AD
Lee, H., Kang, S., Jeong, Y. J., Park, J.-H., Hwang, J.-W., Gu, C.-H., Jung, T.-M., Oh, S., Jang, J.-Y., & Hoe, H. (2025) · Molecular Brain · doi:10.1186/s13041-025-01225-7
The cell autonomous and non-autonomous functions of Rab27 in longevity and neuroprotection in Drosophila
Hsu, C.-H., Li, Y., Guo, T.-N., Tzou, F., Hong, C.-L., Lin, C., Huang, S., & Chan, C. (2025) · Autophagy · doi:10.1080/15548627.2025.2541384 · Cited by 1
Shared pathways in Alzheimer’s disease and type 2 diabetes mellitus
Karmakar, A., Dutta, S., & Mukhopadhyay, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00036-0 · Cited by 2
Simple in vivo models of Alzheimer's disease
Caito, S. W., & Newell-Caito, J. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30008-0.00006-5
Additional file 3 of Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
Shen, Z. J., Fu, Y. B., Hou, J. L., Lin, L. N., Wang, X. Y., Li, C. Y., & Yang, Y. X. (2023) · Figshare · doi:10.6084/m9.figshare.22600132
Additional file 1 of Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathways
Xu, D. C., Sas‐Nowosielska, H., Donahue, G., Huang, H., Pourshafie, N., Good, C. R., & Berger, S. L. (2024) · Figshare · doi:10.6084/m9.figshare.26658526
Additional file 4 of Altered glia-neuron communication in Alzheimer’s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq
Soelter, T. M., Howton, T. C., Clark, A. D., Oza, V. H., & Lasseigne, B. N. (2024) · Figshare · doi:10.6084/m9.figshare.26730970
Additional file 5 of Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
Shen, Z. J., Fu, Y. B., Hou, J. L., Lin, L. N., Wang, X. Y., Li, C. Y., & Yang, Y. X. (2023) · Figshare · doi:10.6084/m9.figshare.22600138
Additional file 6 of Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
Shen, Z. J., Fu, Y. B., Hou, J. L., Lin, L. N., Wang, X. Y., Li, C. Y., & Yang, Y. X. (2023) · Figshare · doi:10.6084/m9.figshare.22600141
Additional file 7 of Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
Shen, Z. J., Fu, Y. B., Hou, J. L., Lin, L. N., Wang, X. Y., Li, C. Y., & Yang, Y. X. (2023) · Figshare · doi:10.6084/m9.figshare.22600144
Additional file 1 of Altered glia-neuron communication in Alzheimer’s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq
Soelter, T. M., Howton, T. C., Clark, A. D., Oza, V. H., & Lasseigne, B. N. (2024) · Figshare · doi:10.6084/m9.figshare.26730961
Additional file 2 of Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
Shen, Z. J., Fu, Y. B., Hou, J. L., Lin, L. N., Wang, X. Y., Li, C. Y., & Yang, Y. X. (2023) · Figshare · doi:10.6084/m9.figshare.22600129
Additional file 4 of Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
Shen, Z. J., Fu, Y. B., Hou, J. L., Lin, L. N., Wang, X. Y., Li, C. Y., & Yang, Y. X. (2023) · Figshare · doi:10.6084/m9.figshare.22600135
Additional file 2 of Altered glia-neuron communication in Alzheimer’s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq
Soelter, T. M., Howton, T. C., Clark, A. D., Oza, V. H., & Lasseigne, B. N. (2024) · Figshare · doi:10.6084/m9.figshare.26730964
Additional file 2 of Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathways
Xu, D. C., Sas‐Nowosielska, H., Donahue, G., Huang, H., Pourshafie, N., Good, C. R., & Berger, S. L. (2024) · Figshare · doi:10.6084/m9.figshare.26658529
Additional file 1 of Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
Shen, Z. J., Fu, Y. B., Hou, J. L., Lin, L. N., Wang, X. Y., Li, C. Y., & Yang, Y. X. (2023) · Figshare · doi:10.6084/m9.figshare.22600126
Additional file 3 of Altered glia-neuron communication in Alzheimer’s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq
Soelter, T. M., Howton, T. C., Clark, A. D., Oza, V. H., & Lasseigne, B. N. (2024) · Figshare · doi:10.6084/m9.figshare.26730967
Metabolic reprogramming in Alzheimer’s disease: Interaction between receptor tyrosine kinase signaling, noncoding RNAs, and Neuron–Glia energy networks
Karmakar, A., Roycowdhury, P., Sengupta, P., & Mukhopadhyay, D. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.02.007
The properties of fibro-adipogenic progenitors in normal regenerating skeletal muscle and degenerative myopathies
Panci, X. (2022) · theses.fr (ABES) · doi:10.70675/4c60262fz385az466fza626z13d037c2cb7f
Development of tacrine-based multitarget-directed ligands as dual AChE/EGFR inhibitors with neuroprotective activity
Wei, Y., Zhang, A., Qiu, W., Xiong, B., Song, Z., Zheng, N., Wu, Y., Zhang, C., Cao, Z., Wang, X., et al. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118677
Protein kinase inhibitors for treatment of Alzheimer’s disease
Kim, C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45844-6.00012-3
Exposure to oligomeric and fibrillar species of amyloid-β induces toxicity and impairs extravillous trophoblast cell function in vitro
Fagla, B. M., Zhao, G., Valencia‐Olvera, A. C., Weng, J. M., Rosa, C. D., Ticiani, E., Tai, L. M., Veiga-Lopez, A., & Buhimschi, I. A. (2026) · Placenta · doi:10.1016/j.placenta.2026.06.015
Isoform Remodeling and Promoter Switching Identify Altered Transcriptional Regulation in Alzheimer's Disease Frontal CortexPreprint
Aquino, J., Lee, A., Zheng, J., Ku, W. L., Han, M., & Chen, J. (2026) · Research Square · doi:10.21203/rs.3.rs-10820900/v1
Alzheimer’s disease target and drug discovery by leveraging multiomics and electronic health data
Hou, Y., Li, Y., Zhang, P., Lorincz‐Comi, N. J., Gohel, D., Fan, F., Qiu, Y., Yang, J., Chen, X., Song, W., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02472-0
BindingDB Entry 50046014: Nodulisporiviridins A-H, Bioactive Viridins from Nodulisporium sp.
BindingDB (2016) · UC San Diego · doi:10.7270/q2rv0qd4

Authors: Wang, L., Chiang, H.-C., Wu, W., Liang, B., Xie, Z., Yao, X., Ma, W., Du, S., & Zhong, Y.
Affiliations: Tsinghua University (CN)
Cold Spring Harbor Laboratory (US)
Tsinghua Shenzhen International Graduate School (CN)
Hainan Normal University (CN)
JoeKai Biotech, LLC, Beijing 100084, China; and
Division of Life Science and Health, Graduate School at Shenzhen, Tsinghua University, Shenzhen 518055, China;
ORCID: Wang, Lei
Chiang, Hsueh-Cheng
Wu, Wenjuan
Ma, Weiwei
Zhong, Yi
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2012-09-27
Volume: 109
Issue: 41
Pages: 16743-16748
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1208011109
PMC: PMC3478595
OpenAlex: W2091619946
Cited by: 190
References: 45
Citations by year: 2026: 9 · 2025: 16 · 2024: 21 · 2023: 25 · 2022: 14 · 2021: 18 · 2020: 13 · 2019: 11 · 2018: 8 · 2017: 14 · 2016: 8 · 2015: 11 · 2014: 14 · 2013: 6 · 2012: 2
FWCI: 7.07
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: epidermal growth factor receptor, amyloid-beta, Alzheimer's disease, memory loss, amyloid-beta oligomers, synaptic plasticity, behavioral screening, synthetic compounds, drug repurposing, transgenic mouse model
MeSH terms: Erlotinib Hydrochloride, Gefitinib, Animals, Chlorocebus aethiops, Drosophila, Drug Evaluation, Preclinical, Humans, Memantine, Memory, Memory Disorders, Mice, Transgenic, Peptide Fragments, Quinazolines, Blotting, Western, Molecular Structure, Amyloid beta-Peptides, Maze Learning, COS Cells, Drosophila Proteins, Animals, Genetically Modified, Protein Kinase Inhibitors, Mice, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Epidermal growth factor receptor is a preferred target for treating Amyloid-β–induced memory loss

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks